Scient'x USA Strengthens Leadership Team With Appointment of Bryce IntVeld as Vice Presiden...( MAITLAND Fla. Dec. 12 /- Scient'x...),Health
Navigation Links
Scient'x USA Strengthens Leadership Team With Appointment of Bryce IntVeld as Vice President of Sales
Date:12/12/2007
MAITLAND, Fla., Dec. 12 /PRNewswire/ -- Scient'x USA, an innovative leader in the development and marketing of products for the surgical treatment of spinal disorders, announced today that Bryce T. IntVeld has joined the Company as Vice President of Sales. In this position, Mr. IntVeld will provide leadership and oversee the establishment and expansion of sales activities in the in U.S. market.
"We are delighted to have Bryce as a member of our executive management team," commented Timothy Seese, Chief Operations Officer of Scient'x USA. "We are confident that Bryce's proven ability to build and lead sales teams will benefit our organization as we continue to grow."
"I am excited about the prospects for Scient'x," stated Mr. IntVeld. "The company has introduced an impressive array of innovative spinal products to the U.S. marketplace and is poised to be a leader in the areas of dynamic stabilization and motion preservation in the U.S. I look forward to helping Scient'x boost its momentum and expand its reach in the fastest growing segment of the orthopaedic market."
Prior to joining Scient'x USA, Mr. IntVeld held several key positions for NuVasive, Inc. Previously, Mr. IntVeld also served as President of MedTech, Inc. and Director of Sales and Marketing for Shevlin Medical, Inc. In addition, Mr. IntVeld has also served as a sales representative for Danek Medical, and has held various other sales management positions within the orthopaedic industry.
About Scient'x USA
Established in 2002, Scient'x USA is focused on the newly evolving markets for dynamic stabilization and motion preservation technologies for spinal surgery. The company is dedicated to meeting the needs of spine surgeons treating increasingly younger and more active patients. More information on the company and its products can be found at http://www.scientxusa.com.
Scient'x USA Inc. is a diversified
'/>"/>
| SOURCE Scient'x USA Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. Kenyan malaria success strengthens call for free insecticide-treated nets for all
2. International study strengthens case for daily calcium pill
3. Wachovia Strengthens Its Healthcare Industry Receivables and Cash Management Capabilities
4. Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
5. Publicis Groupe Strengthens its Leadership in Digital and Integrated Healthcare Communications in Italy
6. NIAID strengthens and expands Vaccine and Treatment Evaluation Units
7. Pieris Strengthens its Management, as it Prepares for the Clinical Development of PRS-050, an Anticalin(R)-Based Novel Cancer Therapy
8. Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based Diagnostic Products in 2008
9. Start Licensing, Inc. Further Strengthens Position in Cloning Industry With New Patents
10. Yakima Health Care Leader Tapped for Leadership Post at National Association
11. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
Post Your Comments:
(Date:12/5/2009)--In Youngest Babies, This Type of Blood Cancer Is Most Challenging-- ,, PHILADELPHIA and NEW ORLEANS, Dec. 5 Pediatric oncologists have identified specific genes, dubbed partner genes, that fuse w
(Date:12/5/2009)Research debunks the ,something,s wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor single people who pass their 40th birthday without ever tying the knot, s
(Date:12/5/2009)The MAMA campaign is a collaborative effort by the National Association of Certified Professional Midwives (NACPM), Midwives Alliance of North America (MANA), Citizens for Midwifery (CfM), Internation
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
Breaking Medicine News(10 mins):Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2[0] New Gene Findings Will Help Guide Treatment in Infant Leukemia[0] Never Married, Over 40, Well-Adjusted[0] AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign [0] Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share[0] Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference
...s today filed an appeal in their challenge of a co...eld by the Wisconsin Alumni Research,Foundation (W... for Taxpayer and Consumer,Rights, and the Public ...s requested a re-examination of the patent,in July...
...nnipeg (July 18, 2008) Funding of $4.4 million fr...R) was announced today by Steven Fletcher, MP for ... Secretary for Health, on behalf of Tony Clement, ...Health Commission of Canada is contributing $250,0...
...chigan State University scholar refutes commonly h..., more emotionally unstable and harder to get alon...ith the findings, employers are urged to guard aga...ent, and two colleagues studied the relationship b...
...paign to raise awareness, of the importance of t... compliance rates across the United St...ation, a,nonprofit organization dedicated to healt...ay, July 19 in conjunction,with the Ebenezer Afric...
...eld,United Concordia Companies, Inc. and Catholic ...es and lifestyles for Pittsburghers. Beginning at ...y 19, a free clinic will,offer health information ...re than other aspects of health care. The percepti...
...t old drug offers new hope , , FRIDAY, Jul...ne step back in the search for treatments against ...e July 19 issue of The Lancet , an older drug cal...er,s -- even though it cleared dementia-linked amy...
Other Medicine News:Health News:Consumer Groups File Appeal on Challenge of Human Stem Cell Patent Held By WARF 2Health News:CIHR announces $4.4 million to improve mental health of Canadians 2Health News:Studies refute common stereotypes about obese workers 2Health News:The COSHAR Foundation Participates in Annual Women's Health Awareness Day 2Health News:The COSHAR Foundation Participates in Annual Women's Health Awareness Day 3Health News:Highmark Blue Cross Blue Shield, United Concordia and Catholic Charities Join Forces to Offer Free Health, Dental Services This Saturday 2Health News:Alzheimer's Research Brings Progress, Setbacks 2Health News:Alzheimer's Research Brings Progress, Setbacks 3Health News:Alzheimer's Research Brings Progress, Setbacks 4Consumer Groups File Appeal on Challenge of Human Stem Cell Patent Held By WARFCIHR announces $4.4 million to improve mental health of CanadiansStudies refute common stereotypes about obese workersThe COSHAR Foundation Participates in Annual Women's Health Awareness DayHighmark Blue Cross Blue Shield, United Concordia and Catholic Charities Join Forces to Offer Free Health, Dental Services This SaturdayAlzheimer's Research Brings Progress, Setbacks
(Date:12/4/2009)SALT LAKE CITY, Dec. 4 Dynatronics Corporation (Nasdaq: DYNT ) announced it has signed a sole-source vendor agreement to provide therapy equipment and rehab supplies to Benchmark Physical Therapy wi
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d
(Date:12/4/2009)LAKE FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: HSP ), a leading global specialty pharmaceutical and medication delivery company, today announced the launch of its next-generation 50 mL and 100 mL V
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 1ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 2ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 3ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 4ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 5EUCODIS Bioscience Launches Beta Lactamase for Antibiotics and Diagnostics Industries 12462 1EUCODIS Bioscience Launches Beta Lactamase for Antibiotics and Diagnostics Industries 12462 2Cardiac Science to Present at Needham Biotechnology 26 Medical Technology Conference 47874 1Cardiac Science to Present at Needham Biotechnology 26 Medical Technology Conference 47874 2Cardiac Science to Present at Needham Biotechnology 26 Medical Technology Conference 47874 3... BETHESDA, Md., Sept. 13 Sucampo,Pharmaceuticals,...North,America, Inc. today announced that the first... lubiprostone (24 mcg, oral gel capsules, twice da...function (OBD). The OBD,Pivotal Assessment of Lubi...uble-blind studies, followed by a nine-month open-...
...t this Common Condition, MILWAUKEE, Sept. 13 US ...ency Milwaukee hotel (333 West Kilbourn Avenue,Mil...m to talk about her,experience with stress urinary... What,s Happening Down There?: Breaking the Ice Ab...a residents are invited to a free,educational even...
Other Medicine Technology:Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD) 2Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD) 3Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD) 4Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD) 5Bonnie Blair to Break the Ice About Stress Urinary Incontinence in Milwaukee 2Bonnie Blair to Break the Ice About Stress Urinary Incontinence in Milwaukee 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |